- Title: Subtitle
- POSTER: MM-846: Treatment-Related Mortality and Predictors in Real-World Patients With Relapsed/Refractory Multiple Myeloma Treated With Teclistamab
- Creators
- Osama Younis - University of JordanSencer Goklemez - University of CincinnatiCarmel Awadallah - St. Luke's Episcopal HospitalBarry Paul - Levine Cancer InstituteHira Shaikh - University of IowaChristopher Strouse - University of IowaAnita Mazloom - USA Mitchell Cancer InstituteOmar Alkharabsheh - University of CincinnatiPrerna Mewawalla - Allegheny Health NetworkMansi Shah - Rutgers, The State University of New JerseyZahra Mahmoudjafari - University of Kansas Medical CenterJordan Snyder - University of Kansas Medical CenterMuhammad Umair Mushtaq - University of Kansas Medical CenterJeries Kort - University of Kansas Medical CenterAlma Habib - University of Kansas Medical CenterAl-Ola Abdallah - University of Kansas Medical CenterAbdullah Mohammad Khan - The Ohio State UniversityShebli Atrash - Levine Cancer Institute
- Resource Type
- Abstract
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.26(Suppl 1), pp.S344-S344
- DOI
- 10.1016/S2152-2650(26)01373-X
- ISSN
- 2152-2650
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 08/2026
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9985222739502771
Abstract
POSTER: MM-846: Treatment-Related Mortality and Predictors in Real-World Patients With Relapsed/Refractory Multiple Myeloma Treated With Teclistamab
Clinical lymphoma, myeloma and leukemia, Vol.26(Suppl 1), pp.S344-S344
08/2026
DOI: 10.1016/S2152-2650(26)01373-X
Details
Metrics
1 Record Views